Literature DB >> 4206830

Unresponsiveness to thyrotropin-releasing hormone (TRH) in treated Graves' hyperthyroidism and in euthyroid Graves' disease.

P Clifton-Bligh, G E Silverstein, G Burke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4206830     DOI： 10.1210/jcem-38-4-531

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

1.  Response to TRH, serum thyroid hormone concentration, and serum markers of autoimmunity after antithyroid therapy in Graves' disease.

Authors:  B A Lamberg; A Aro; P Saarinen; T Tötterman; T Mäkinen
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

2.  Case reports. Graves hyperthyroidism following myxedema in a patient with recurrent carcinoma of the colon.

Authors:  G A Levine; D E Williams; J M Hershman; G N Beall
Journal:  West J Med       Date:  1978-03

3.  Prolonged drug treatment of hyperthyroidism.

Authors:  B A Burrows; D W Slingerland
Journal:  Trans Am Clin Climatol Assoc       Date:  1977

4.  Clinical application of a cytochemical bioassay for the determination of thyroid stimulating hormone.

Authors:  T Hashimoto; K D Döhler; D Emrich; A von zur Mühlen
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

5.  Thyroid-stimulating hormone (tsh), triiodothyronine (t3) and thyroxine (t4) response to intravenous and oral stimulation with synthetic thyrotropin-releasing hormone (trh) in young healthy adults.

Authors:  P Vogt; J Girard; J J Staub
Journal:  Klin Wochenschr       Date:  1978-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.